Innovative payment schemes are bi- or multi-lateral agreements that support medical technologies and procedures that do not fit well or do not meet the criteria for the existing reimbursement and funding frameworks.
European countries have around 25 innovative payment schemes that support evidence generation or early adoption of medical technologies. Most (~70%) of innovative payment schemes allow for direct application by industry stakeholders or physicians/providers/researchers.
Our latest White Paper offers a summary of innovative payment schemes for medical devices that permit direct applications by the Med Tech industry, including the Innovative Devices Access Pathway (IDAP) in the UK, Forfait Innovation and Article 51 in France, and co-funded clinical studies under §137e in Germany.
This resource equips stakeholders with actionable insights to effectively navigate these frameworks, secure reimbursement for their technologies, and position their innovations for success within the evolving European healthcare landscape.
Request White Paper
Request an analytical White Paper and get strategic insights into European Innovative Payment Schemes.